glp 1 access Medicare expands to GLP-1 weight loss drugs Care Access | Weight Loss
Description
Dose changes are best based on a full picture, including appetite, side effects, routine, and weight trend

For this reason, these medications are often used in people with type 2 diabetes who also have heart or kidney problems

Thoughtful dose selection, kidney-based adjustments, and awareness of rare but serious risks support safe use

Long-term use of GLP-1 receptor agonists is being actively studied, with many patients experiencing continued appetite control and weight stabilization over time

But if we can see, by reduction in insulin resistance, reduction in inflammation, reduction in hormone-based cancers an improvement that is really going to be exciting

2024;2024:CD006257
